Skip to content
HowShorted

Monopar Therapeutics short interest in 2023

In 2023, Monopar Therapeutics's disclosed short interest ran from 0.10% of shares outstanding on 13 Jan 2023 to 0.71% on 29 Dec 2023, a change of +0.61 percentage points. The year's high was 1.26% on 15 Nov 2023 and its low 0.10% on 13 Jan 2023, averaging 0.56% across 20 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 4.96 days on 28 Apr 2023. Full history: Monopar Therapeutics.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Monopar Therapeutics in 2023

2023 in figures

Start of year
0.10% (13 Jan 2023)
End of year
0.71% (29 Dec 2023)
Change
+0.61 pp
High
1.26% (15 Nov 2023)
Low
0.10% (13 Jan 2023)
Average
0.56%
Highest days to cover
4.96 (28 Apr 2023)
SEC filings marked
8

Every report in 2023

Monopar Therapeutics short interest in 2023
SettlementShort interestDays to coverFilings since previous
13 Jan 20230.10%1.99
15 Feb 20230.25%1.00
28 Feb 20230.31%2.72
15 Mar 20230.50%4.33
31 Mar 20230.70%1.0610-K filed, results (8-K)
14 Apr 20230.47%2.58
28 Apr 20230.57%4.96
15 May 20230.60%4.0110-Q filed, results (8-K)
31 May 20230.64%1.00
30 Jun 20230.88%1.26
31 Jul 20230.43%1.00
31 Aug 20230.68%1.7110-Q filed, results (8-K)
15 Sep 20230.46%2.63
29 Sep 20230.26%2.20
13 Oct 20230.33%2.35
31 Oct 20230.35%4.05
15 Nov 20231.26%1.0010-Q filed, results (8-K)
30 Nov 20231.14%2.16
15 Dec 20230.47%1.00
29 Dec 20230.71%1.00

See also: Monopar Therapeutics's full history · most shorted US stocks of 2023 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.